virus

Oxford starts human testing of Nipah virus vaccine

The University of Oxford has initiated human testing for an experimental vaccine against the Nipah virus, which has caused deadly outbreaks in Asia. The initial trial will assess safety and immune response and involves participants aged 18 to 55. The vaccine is based on the same technology used in AstraZeneca and Serum Institute of India's COVID-19 shots. The research is funded by the Coalition for Epidemic Preparedness Innovations. Further trials in Nipah-affected countries are anticipated.

Punjab health minister’s important message on flu virus

Caretaker Punjab Health Minister Dr. Javed Akram clarified that a new flu virus has emerged in Punjab, unrelated to coronavirus. He advised wearing warm clothing to prevent infection and addressed the smog issue, attributing it to stubble burning. Health experts highlighted the virus's symptoms and its potential for person-to-person transmission. Air pollution in Pakistan has worsened.